Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tarrytown, New York
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- N/A
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1295947
- Fiscal year ends
- March
- Filer status
- Large accelerated filer
Financials 8 of 73
News 8 of 167
- 8-K Quarterly results Nov 5, 2026
- 8-K Leadership change Aug 14, 2026
- 8-K Quarterly results Aug 6, 2026
- 8-K Significant contract Jul 15, 2026
- 8-K/A Current report on a material event, amended Jul 9, 2026
- 8-K Significant contract Jul 6, 2026
- 8-K/A Current report on a material event, amended Jun 30, 2026
- 8-K Significant contract Jun 16, 2026
Prospectuses and Registrations 8 of 11
- S-8 Registration statement for an employee plan Aug 4, 2020
- S-8 POS Post-effective amendment to an employee plan registration May 15, 2019
- S-8 POS Post-effective amendment to an employee plan registration May 15, 2019
- S-8 Registration statement for an employee plan Aug 28, 2014
- 424B3 Prospectus supplement for an offering Jul 13, 2012
- S-4 Registration statement for a merger or exchange Jul 2, 2012
- 424B3 Prospectus supplement for an offering Aug 4, 2011
- S-4/A Registration statement for a merger or exchange, amended Jul 29, 2011
Proxies 8 of 24
- DEF 14A Proxy statement for a shareholder vote Jun 29, 2026
- DEF 14A Proxy statement for a shareholder vote Jun 27, 2025
- DEF 14A Proxy statement for a shareholder vote Jul 5, 2024
- PRE 14A Preliminary proxy statement Jun 24, 2024
- DEF 14A Proxy statement for a shareholder vote Jun 29, 2023
- DEF 14A Proxy statement for a shareholder vote Jun 28, 2022
- DEF 14A Proxy statement for a shareholder vote Jun 29, 2021
- DEF 14A Proxy statement for a shareholder vote Jun 29, 2020
Ownership 8 of 661
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 7, 2026
- 4/A Insider reported a trade, amended May 14, 2026
- 4 Insider reported a trade May 12, 2026
Other 8 of 65
- ARS Annual report sent to shareholders Jun 29, 2026
- ARS Annual report sent to shareholders Jun 27, 2025
- ARS Annual report sent to shareholders Jul 5, 2024
- ARS Annual report sent to shareholders Jun 29, 2023
- SEC STAFF LETTER Sep 26, 2019
- SEC STAFF LETTER Sep 12, 2019
- UPLOAD Comment letter from SEC staff Mar 4, 2016
- CORRESP Reply to SEC staff Mar 3, 2016
Everything here comes from Prestige Consumer Healthcare Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.